Dr. Federico Canzian
Funktion: Gruppenleiter
Bereich: Genomische Epidemiologie
Kontakt: zum Kontaktformular
Telefonnr.: 0 62 21.42-17 91
Fax: 0 62 21.42-22 03
Gebäude: TP 4
Raum: S3.204
Werdegang
1987-1992 M.Sc. in Biologie, Universität Milano, Italien
1993-1998 PhD in Biotechnologie, School of Specialization in Biotechnology, Milano, Italien
Forschungsgebiet
Genetik der Krebsanfälligkeit, genetische Polymorphismen, Assoziationsstudien, Krebsepidemiologie, Krebsgenomik, Bioinfomatik
Ausgewählte Publikationen
Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils C, Peeters PHM, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R. Genetic variation in the growth hormone synthesis pathway in relation to circulating IGF-I, IGFBP-3, and breast cancer risk: results from the EPIC study. Cancer Epidemiol Biomarkers Prev 2005;14:2316-2325.
Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S, Landi S, Boillot C, Monnier S, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PHM, Pera G, Ardanaz E, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 2006;94:299-307.
Campa D, Vodicka P, Pardini B, Novotny J, Försti A, Hemminki K, Barale R, Canzian F*. Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk? Eur J Cancer 2008;44:854-7.
Canzian F*, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, Bingham S, Boeing H, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Dossus L, Feigelson HS, Haiman CA, Hankinson SE, Hoover R, Hunter DJ, Isaacs C, Lenner P, Lund E, Overvad K, Palli D, Pearce CL, Quiros JR, Riboli E, Stram DO, Thomas G, Thun MJ, Trichopoulos D, van Gils CH, Ziegler RG for the Breast and Prostate Cancer Cohort Consortium. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer 2009;9:257.
Wilkening S, Chen B, Lorenzo Bermejo J, Canzian F*. Is there still a need for candidate gene approaches in the era of genome-wide association studies? Genomics 2009;93:415-419.